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Objectives. We attempted to determine the prevalence of 
strands on native and prosthetic valves, as detected by transesoph- 
ageal echocardiography, and to assess the relative risk for sys- 
temic emboli associated with these strands. 
Background. Fine threadlike strands, seen on native and pros- 
thetic valves by transesophageal echocardiography, have been 
implicated in systemic embolization. 
Methods. During a 2-year period, 1,559 patients underwent 
transesophageal echocardiography at our center. Of these, 41 
patients had strands and no other identifiable source of systemic 
emboli. They were matched for age, gender, history of hyperten- 
sion and history of smoking with a control group of 41 patients 
without strands who also had no identifiable source of emboli. The 
risk of embolization in the two groups was compared. 
Results. Of 1,559 patients studied by transesophageal echocar- 
diography, 86 (5.5%) had strands. Strands were far more common 
on mitral valves than on aortic valves. Of the patients with 
strands, 38% had had an event consistent with a systemic embo- 
lus, whereas 62% had not. Of 597 patients with an embolic event, 
63 (10.6%) had strands, whereas only 23 (2.3%) of 962 patients 
without emboli had strands. In the case-control study, 33 (83%) of 
the 41 patients with strands without another source of embolism 
had emboli compared with only 12 (29%) of the 41 control patients 
without another source (odds ratio 10.0, 95% confidence interval 
3.6 to 27.8, p = 0.00001). 
Conclusions. Valvular strands visualized by transesophageal 
echocardiography are associated with systemic embolization. 
(J Am CoU Cardioi 1995;26:1709-12) 
Transesophageal echocardiography is an important modality 
for evaluating potential sources of systemic emboli (1). The 
technique has been particularly valuable in identifying aortic 
atheromas (2), valvular vegetations (3) and masses (4), left 
atrial thrombi (5), spontaneous echo contrast (6) and inter- 
atrial shunts (7). 
Fine threadlike strands, seen on native and prosthetic 
valves, have also been implicated in systemic embolization (8). 
We studied the prevalence of this finding in patients referred 
to our laboratory for transesophageal echocardiography, and 
we assessed the relative risk for systemic emboli associated 
with these strands in the absence of other identifiable sources 
of peripheral emboli. 
Methods  
Patients. Between 1991 and August 1993, 1,559 patients 
underwent ransesophageal echocardiography in the New 
York University Medical Center Non-Invasive Cardiology 
Laboratory. These patients were the subjects of this study. 
All patients were referred for transesophageal echocardi- 
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ography by their private physician. Clinical information was 
obtained from the patients and, in the case of inpatients, from 
the hospital chart, at the time of the transesophageal study. 
Transesophageal eehocardiography. Transesophageal 
echocardiography was performed in the echocardiography 
laboratory on awake patients, after a 4-h fast, with no premed- 
ication other than topical lidocaine spray. Images were ob- 
tained by using a Hewlett-Packard Sonos 1000 with a 5-MHz 
biplane transducer or a Sonos 1500 with a 5-MHz omniplane 
transducer. 
Yransesophageal echocardiograms were reviewed by one or 
two experienced echocardiographers; the report of their find- 
ings formed the data base from which conclusions were made 
regarding the presence or absence of strands. 
Strands were defined as highly mobile, fine, threadlike 
excrescences, -< 1 mm in width, attached to native or prosthetic 
valves (Fig. 1). They varied in length from -0.5 to -3.0 era. 
Sessile or pedunculated valvular lesions >1 mm in width were 
not classified as strands. Usually pedunculated lesions were 
identified as typical vegetations, bland thrombi or verrucous 
vegetations, and the more sessile lesions were consistent with 
fibroelastomas. We excluded patients with obvious torn chor- 
dae or flail leaflets to avoid the possibility of confusing torn or 
redundant chordae with strands. Interobserver variability for 
the detection of strands was assessed. 
Native valves were graded as either normal or trivially 
thickened or, alternatively, as significantly thickened. Any 
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Figure 1. Magnified ho~ntal transesophageal image of a mitral 
valve strand (arrows). Because these strands are thin and may be quite 
long, their continuity may not be apparent on a single two-dimensional 
still frame. They are therefore best seen in real time. LA = left atrium. 
valve that had a typically myxomatous or rheumatic appear- 
ance was automatically classified as "significantly thickened." 
Statistical analysis. Nonparametric variables were com- 
pared by using the chi-square test, and estimated odds ratios 
and 95% confidence intervals were calculated. A p value < 
0.05 was considered significant. 
Resu l ts  
Overall prevalence of strands. Among 1,559 patients tud- 
ied by transesophageal chocardiography in our laboratory, 
strands were identified in 86 (5.5%). The patients ranged in 
age from 23 to 93 years (mean 66). 
Distribution of strands. Among the 86 patients with strands, 
the strands were located on the mitral valve in 60 (70%), the 
aortic valve in 23 (27%) and both left heart valves in 3 (3%). 
Morphology of valves with strands. Of the 89 valves with 
strands, 79 (89%) were either morphologically normal or 
minimally thickened native valves, 7 (8%) were significantly 
thickened native valves and 3 (3%) were mechanical prosthe- 
ses. There were no porcine prostheses with strands. 
Prevalence of strands in patients with and without an 
elnbolic event. Of the 1,559 patients tudied by transesopha- 
geal echocardiography, 597 (38%) had had an event hat, on 
clinical grounds, was consistent with a systemic embolus. 
Embolic events included strokes, transient ischemic attacks or 
peripheral emboli. Some of these patients had radiologic or 
surgical documentation f an embolus. In some cases, it is of 
course ditficult o distinguish between embolic and thrombotic 
events. Nine hundred sixty-two patients (62%) had no history 
suggesting an embolus. 
Strands were far more common in patients with emboli. Of 
the 597 patients with an embolic event, 63 (10.6%) had strands, 
compared with only 23 (2.3%) of the 962 patients without an 
embolic event (odds ratio 4.8, 95% confidence interval [CI] 3.0 














41 Strand 41 Controls 
Pts 
Figure 2. Prevalence of clinical vascular events (solid bars) in 41 
patients (Pts) with strands versus that in 41 control patients without 
strands. Open columns = no events. Odds ratio 10.0, 95% confidence 
interval 3.6 to 27.8, p = 0.00001. 
Case-control study. Forty-one of the 86 patients with 
strands had no other identifiable potential source of systemic 
emboli. Other potential sources were defined as a history of 
atrial fibrillation, presence of intracardiac clot or spontaneous 
echo contrast, patent foramen ovale or atrial septal defect, 
aortic atheroma or carotid artery disease (determined by 
carotid duplex ultrasonography, contrast angiography ormag- 
netic resonance angiography). 
The 41 patients with no other embolic source formed the 
study group. They were randomly matched for age, gender, 
history of hypertension and history of smoking with 41 other 
patients without strands on transesophageal chocardiography 
who also had no identifiable source of emboli. The latter 41 
patients erved as the control group. 
There was no significant difference between the two groups 
with respect to the presence of a prosthetic valve (four patients 
with strands vs. seven control patients, p = NS) or the use of 
anticoagulant or antiplatelet therapy (22 patients with strands 
vs. 22 control subjects, p = NS). 
Of the 41 patients with strands, 33 (83%) had emboli; of the 
41 control patients, only 12 (29%) had emboli (odds ratio 10.0, 
95% CI 3.6 to 27.8, p = 0.00001) (Fig. 2). 
Identification of strands. To assess interobserver variabil- 
ity and to ascertain whether there was any observational bias 
with regard to the detection of strands, the transesophageal 
echocardiograms of the 82 patients in the retrospective case- 
control study were reviewed asecond time by two echocardio- 
graphers who had no knowledge of the clinical indications for 
the studies or the previously determined results. 
Of the 164 valves seen a second time by one of two 
echocardiographers, 4 valves initially thought o bear strands 
were interpreted as not having strands, and 4 valves initially 
thought not to bear strands were interpreted as having strands 
on the second reading. With the four false positive results 
(2.4%) and four false negative results (2.4%), concordance 
with the original interpretation was 95% for the 164 valves and 
91% for the 82 patients (1 patient had 2 valves that were read 
discordantly). 
Of these 82 studies, 78% were performed with biplane 
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transducers and 22% with omniplane transducers. The zoom 
modality was used in 40% of the studies. However, in only two 
cases did the zoom permit visualization of strands that were 
not seen without zoom. 
Discuss ion  
Preponderance of mitral valve involvement. In our series, 
as in others, valvular strands were more commonly seen on 
mitral than on aortic valves. This echocardiographic observa- 
tion may, in part, be due to the close proximity of the mitral 
valve to the transesophageal transducer, and hence to the 
superior esolution of the mitral valve and its paravalvular 
structures. Alternatively, it may reflect a real anatomic differ- 
ence between mitral and aortic valves and divergent propen- 
sities for strand formation. 
Association of strands with emboli. There was a highly 
significant difference in the prevalence of strands in patients 
studied by transesophageal chocardiography because of an 
embolic event versus that in patients studied for another 
indication. Although different in degree, the divergent preva- 
lences of strands in these two groups in our study (10.6% in 
those with an embolic event vs. 2.3% in those without a history 
of an embolus) parallel those in previous reports. In a prospec- 
tive series of 50 patients (without significant carotid artery 
disease and with a nonrevealing transthoracic echocardio- 
gram) studied by transesophageal chocardiography because 
of a stroke or transient ischemic attack, Lee et al. (8) reported 
a 22% prevalence of mitral strands. The higher prevalence in
their series may reflect heir more liberal definition of strands, 
which included excrescences >1 mm in width. Pearson et al. 
(9) found mitral strands in 5% of 318 patients with stroke and 
in only 0.3% of 650 patients not being studied because of an 
embolus. 
By not including patients with torn chordae or flail mitral 
leaflets, we may have excluded some patients with myxomatous 
degeneration who had strands but were referred for evaluation 
of valvular insufficiency and not for emboli. Thus, our exclusion 
criteria may have led to a greater difference in the prevalences 
of strands in the groups with and without emboli than would 
have occurred if these patients had been included. Alterna- 
tively, the exclusion of some patients with valvular morpholo- 
gies that are known to be associated with a higher incidence of 
cerebrovascular events and possibly a higher incidence of 
strands (i.e, myxomatous valves), may have led us to underes- 
timate both the overall prevalence of strands in the patients 
referred for transesophageal chocardiography and, in partic- 
ular, the prevalence ofstrands in those referred specifically for 
evaluation of embolization. 
Another possible limitation of our case-control (retrospec- 
tive) study was the matching of only four variables that may 
contribute to embolic risk. In addition, the case-control design 
does not eliminate any possible referral basis. 
Etiology of strands. The etiology of valvular strands re- 
mains unclear. None of our patients with strands underwent 
cardiac surgery that might have provided pathologic data 
regarding the composition of strands. Lee et al. (8) described 
one patient with a thickened mitral valve and strands who 
underwent valve replacement because of mitral regurgitation. 
Pathologic examination of the strands attached to the excised 
valve revealed Lambl's excrescences. Lambl originally de- 
scribed these filamentous processes on the ventricular surface 
of an aortic valve, but these same excrescences were subse- 
quently described on the atrial surfaces of the atrioventricular 
valves. 
Magarey (10), who studied these xcrescences on 250 mitral 
valves, suggested that they were more common with advanced 
age. This led him to speculate that they were due to fibrin 
deposition over damaged endocardial valvular surfaces that 
subsequently became partially detached from the valve, con- 
densed and hyalinized, and ultimately fibrosed. Fresher fibrin 
deposits were found to be enmeshed with erythrocytes and 
leukocytes. 
Relation to valve morphology. Magarey reported that 
Lambl's excrescences were more commonly found on thick- 
ened valves. This observation is not surprising because valvular 
thickening (as seen with rheumatic valves) or redundancy (as 
seen with myxomatous valves) may predispose valves to fissur- 
ing of their endothelial surfaces, thus rendering them throm- 
bogenic. Indeed, Lee et al. (8) also suggested that mitral 
thickening visualized by echocardiography was associated with 
a higher incidence of mitral valve strands. However, both 
Magarey (10), in his pathologic description of Lambl's excres- 
cences, and Lee et al. (8), in their series of stroke patients with 
strands, included valvular excrescences >1 mm in width; in 
fact, both studies included lesions up to 5 mm in width. 
In our series, strands were more common on normal native 
valves than on valves that were significantly thickened. How- 
ever, we excluded excrescences > 1mm in width. In addition, it
is possible that our exclusion of valves with torn chordae or flail 
leaflets excluded a few myxomatous or other morphologically 
abnormal valves that also had strands. 
Whether strands on native valves and those on prosthetic 
valves identified by transesophageal chocardiography repre- 
sent the same morphologic entity is not clear. However, the 
greater prevalence of strands on prosthetic valves (12% as 
assessed by Orsinelli and Pearson [11] and 18% as assessed by 
lsada et al. [12]) and, in particular, the much greater preva- 
lence on mechanical s opposed to tissue prostheses in both 
series uggest that strands are related to thrombosis. Stoddard 
et al. (13), in fact, reported a startling 75% prevalence of 
strands on St. Jude prostheses in the mitral position. 
With both native and prosthetic valves, strands have been 
reported to be associated with embolization. In the series of 
Orsinelli and Pearson (11), 69% of patients with prosthetic 
valves and systemic embolization had prosthetic valve strands 
in contrast to 12% of patients being studied by transesophageal 
echocardiography because of prosthetic valve dysfunction. 
Isada et al. (12) reported on two patients with strands on 
mechanical prostheses who underwent valve replacement be- 
cause of recurrent embolization; there was pathologic onfir- 
mation of thrombus on both valves. 
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Potential implications. Whether strands or fragments of 
strands themselves embolize, or whether they are merely 
markers for an embolic potential, isnot known. The high preva- 
lence of normal valve morphology inour series uggests hat hey 
are not simply a marker for valve morphologies that may be 
associated with platelet aggregation rclot formation. However, 
they may be a marker of hypercoagulable states that predis- 
pose patients to thromboembolic disease, a possibility that de- 
serves further investigation. We are currently studying the prev- 
alence of anticardiolipin a tibodies in patients with strands. 
Definitive therapy for patients with strands, and particularly 
for those who have already had an embolic event without 
another source for embolism, is undetermined. In our case- 
control study, there was no difference in the use of anticoag- 
ulant or antiplatelet therapy in patients with and without 
strands who had no other identifiable sources of emboli. 
Orsinelli and Pearson (12) reported on a patient who, with a 
prothrombin time in the therapeutic range, had a transient 
ischemic attack and strands on his mitral prosthesis; these 
strands were no longer seen after the addition of dipyridimole 
to his regimen. However, such data are anecdotal. 
Prospective transesophageal echocardiographic follow-up 
studies are needed to assess the efficacy of anticoagulant or
antiplatelet therapy, or both, in eradicating the finding of 
strands. In addition, prospective clinical trials are required to 
determine the efficacy of these approaches in preventing 
embolization i patients with strands. 
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